Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0001415889-25-023899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-08 | 2025-09-04+ | BBNX | Hopman Mark | Chief Commercial Off | M - OptEx | $5.10 | +16.2K | 33.9K | +91% | +$82.4K |
| DM | 2025-09-08 | 2025-09-04+ | BBNX | Hopman Mark | Chief Commercial Off | S - Sale+OE | $20.34 | -18.2K | 31.2K | -37% | -$370.8K |
| DM | 2025-09-08 | 2025-09-04+ | BBNX | Hopman Mark | Chief Commercial Off | M - OptEx | $0.00 | -16.2K | 33.1K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-04 | M | A | 4,093 | $5.10 | 38,033 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-05 | M | A | 11,411 | $5.10 | 42,626 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-04 | M | A | 656 | $5.10 | 33,940 | D | — | — | |
| 4 | Common | Common Stock | 2025-09-05 | S | D | 11,411 | $20.56 | 31,215 | D | — | — | (F3) The weighted average sale price for the transaction reported was $20.564162 and the range of prices were between $20.29 and $20.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 5 | Common | Common Stock | 2025-09-04 | S | D | 6,818 | $19.97 | 31,215 | D | — | — | (F2) The weighted average sale price for the transaction reported was $19.9736 and the range of prices were between $19.43 and $20.10. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2025-09-05 | M | D | 11,411 | $0.00 | 21,725 | D | $5.10 · — to 2033-09-13 | 11,411 Common Stock | (F5) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2025-09-04 | M | D | 656 | $0.00 | 66,428 | D | $5.10 · — to 2033-07-26 | 656 Common Stock | (F4) One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2025-09-04 | M | D | 4,093 | $0.00 | 33,136 | D | $5.10 · — to 2033-09-13 | 4,093 Common Stock | (F5) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |